These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 9137700)

  • 21. [Antiphospholipid antibodies in acute infection caused by hepatitis C virus].
    Merino de Lucas E; Priego Valladares M; Reus Bañuls S; Pérez-Mateo Regadera M
    Med Clin (Barc); 1998 Feb; 110(6):238-9. PubMed ID: 9580405
    [No Abstract]   [Full Text] [Related]  

  • 22. Treatment of chronic hepatitis C with interferon-alpha. Clinical histological and virological implications.
    Olaso V; Córdoba J; Berenguer M; Prieto M; Lainez B; Argüello L; Valverde J; Pascual S; Gobernado M; Berenguer J
    Rev Esp Enferm Dig; 1997 Jul; 89(7):531-50. PubMed ID: 9265839
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interferon-alpha therapy within the first year after acute hepatitis C infection in hemodialysis patients: efficacy and tolerance.
    Rocha CM; Perez RM; Narciso JL; Ferreira AP; Lemos LB; Medina-Pestana JO; Silva AE; Ferraz ML
    Eur J Gastroenterol Hepatol; 2007 Feb; 19(2):119-23. PubMed ID: 17272996
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The advances in the treatment of chronic hepatitis C with interferon].
    Liu TH; Fu XX; Tian GS
    Zhonghua Nei Ke Za Zhi; 1992 Oct; 31(10):650-2. PubMed ID: 1306461
    [No Abstract]   [Full Text] [Related]  

  • 25. [Interferon-alpha and development of psoriatic arthropathy].
    Piqueras Alcol B; de Diego Lorenzo A; Pérez Roldán F; Baños Díaz E; Clemente Ricote G
    An Med Interna; 1996 Oct; 13(10):512-3. PubMed ID: 9019204
    [No Abstract]   [Full Text] [Related]  

  • 26. [Should hepatitis C be treated?].
    Tran A
    Gastroenterol Clin Biol; 1997; 21(1 Pt 2):S148-53. PubMed ID: 9161526
    [No Abstract]   [Full Text] [Related]  

  • 27. [Disappointing response of chronic C hepatitis to interferon].
    Theodor E; Regev A
    Harefuah; 1997 Mar; 132(6):402-3, 447. PubMed ID: 9153855
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential role for antiphospholipid antibodies in renal thrombotic microangiopathy induced by interferon-alpha.
    Piette JC; Papo T
    Nephrol Dial Transplant; 1995; 10(9):1781. PubMed ID: 8559510
    [No Abstract]   [Full Text] [Related]  

  • 29. [Cryoglobulinemia and hepatitis c: worsening of peripheral neuropathy after interferon alpha treatment].
    Lidove O; Cacoub P; Hausfater P; Wechsler B; Frances C; Leger JM; Piette JC
    Gastroenterol Clin Biol; 1999 Mar; 23(3):403-6. PubMed ID: 10384347
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Severe exacerbation of hepatitis C-associated vasculitic neuropathy following treatment with interferon alpha: a case report and literature review.
    Boonyapisit K; Katirji B
    Muscle Nerve; 2002 Jun; 25(6):909-13. PubMed ID: 12115983
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Large dose natural interferon alpha therapy for patients with chronic hepatitis C.
    Ohmiya M; Hayashi J; Furusyo N; Ueno K; Kishihara Y; Nabeshima S; Kashiwagi S
    Fukuoka Igaku Zasshi; 1997 Dec; 88(12):380-8. PubMed ID: 9465478
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic paranoid psychosis and dementia following interferon-alpha treatment of hepatitis C: a case report.
    Drozdz W; Borkowska A; Wilkosc M; Halota W; Dybowska D; Rybakowski JK
    Pharmacopsychiatry; 2007 Jul; 40(4):146-8. PubMed ID: 17694476
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Response of chronic hepatitis C to interferon-alpha treatment and relationship with iron metabolism.
    Martín-Vivaldi R; Nogueras F; González A; Quintero D; Pinel LM; Castro T; Hernández A
    Rev Esp Enferm Dig; 1997 Jul; 89(7):523-30. PubMed ID: 9265838
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Parameters predicting response to alpha-interferon treatment in chronic hepatitis C.
    Glück T; Seelig R; Dette S; Bühring HJ; Renz M; Kwon S; Wiedmann KH; Weber P
    Hepatogastroenterology; 1997; 44(14):484-91. PubMed ID: 9164523
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Results of treatment of hepatitis C with interferon alone or combined with other drugs].
    Serfaty L
    Gastroenterol Clin Biol; 1997; 21(1 Pt 2):S154-66. PubMed ID: 9161527
    [No Abstract]   [Full Text] [Related]  

  • 36. [Autoimmune lesions of thyroid as complications of interferon treatment of chronic viral hepatitis].
    Ettinger OA; Nikitin IG; Storozhakov GI
    Ter Arkh; 1999; 71(12):69-72. PubMed ID: 10647210
    [No Abstract]   [Full Text] [Related]  

  • 37. Interferon-alpha and development of type 1 diabetes: a case without insulin resistance.
    Tohda G; Oida K; Higashi S; Hayashi T; Miyamori I
    Diabetes Care; 1998 Oct; 21(10):1774. PubMed ID: 9773746
    [No Abstract]   [Full Text] [Related]  

  • 38. [Chronic hepatitis C virus positive hepatitis and antiphospholipid syndrome].
    Calvo Romero JM; Díaz Rodríguez E
    Gastroenterol Hepatol; 1998 Nov; 21(9):437-8. PubMed ID: 9882933
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [How to follow treated and untreated chronic hepatitis B and C].
    Adler M; Golstein P; Botembe N; Bourgeois N
    Rev Med Brux; 1997 Sep; 18(4):183-6. PubMed ID: 9411639
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Thyrotoxicosis due to long-term therapy with interferon alpha in the patient with mixed chronic active hepatitis B and C].
    Vortel J; Bures J; Rejchrt S; Zivný P; Palicka V
    Vnitr Lek; 1999 May; 45(5):301-4. PubMed ID: 15641255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.